Tenet Healthcare Corporation logo

Tenet Healthcare Corporation

THC

NYSEHealthcareMedical - Care Facilities

Previous close

$280.77

+$8.17 · +3.00%

Aug 21, 4:00 PM ET

THC company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Buy

Favorable setup — positive multi-factor alignment

Valuation

99

Deep Value

Momentum

50

Neutral

Sentiment

72

Bullish

Risk resilience

60

Moderate Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Tenet Healthcare Corporation operates as a broad-ranging provider of health solutions. The company organizes its operations across three main divisions: Hospital Operations and Other, Ambulatory Care, and Conifer. Within its network of acute care facilities, Tenet delivers a full spectrum of essential services. These include core hospital functions such as operating and recovery suites, radiology and respiratory therapy, clinical laboratories, and on-site pharmacies. The organization also provides high-acuity patient care through intensive, critical, and coronary care units. Specialized medical services cover areas like cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics, alongside various outpatient treatments, including physical therapy. Advanced surgical capabilities feature cardiothoracic, complex spinal, and neurosurgery, as well as neonatal intensive care. Tenet extends its offerings to ultra-specialized quaternary care, exemplified by heart and kidney transplant programs, and sophisticated procedures such as limb-salvaging vascular interventions, acute Level 1 trauma care, intravascular stroke treatment, minimally invasive cardiac valve replacements, advanced imaging, and telemedicine access. Beyond its hospital network, Tenet manages numerous other clinical sites. These encompass outpatient surgical centers, immediate care facilities, diagnostic imaging centers, dedicated surgical hospitals, off-campus emergency departments, and micro-hospitals. Through its Conifer segment, the company furnishes critical healthcare business process solutions. These administrative services, offered to hospitals, health systems, physician practices, employers, and other clients, include financial administration for patient accounts (revenue cycle management), support for patient communications and engagement, and outcome-focused care strategies. As of February 9, 2022, Tenet's operational footprint included 60 hospitals and roughly 550 additional medical facilities. This count of additional sites comprises surgical hospitals, ambulatory surgery centers, urgent care and imaging centers, and various other clinical locations. Tenet Healthcare Corporation was established in 1975 and maintains its principal office in Dallas, Texas.

Industry
Medical - Care Facilities
Sector
Healthcare
Headquarters
US
CEO
Saumya Sutaria
Listed since
Mar 17, 1980
Employees
88,500

Market position

Day range

Current $280.77

52-week range

Current $280.77

Open
$275.62
Previous close
$272.6
Volume
641.56K
0.47× average
Average volume
1.38M
Average daily volume
Market cap
22.61B USD
Beta
1.23
Market reference 1
50-day average
$219.89
+27.68% above average
200-day average
$204.86
+37.05% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
28.2B USD
P/E (TTM)
10.75×
P/B (TTM)
5.03×
P/S (TTM)
1.04×
EV / EBITDA
6.29×
Earnings yield
7.85%
Free cash flow yield
14.12%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
26.87%
Operating margin
16.80%
Net margin
10.27%
Return on equity
33.34%
Return on assets
4.74%
Return on invested capital
11.49%

Financial health

Debt / equity
2.84×
Current ratio
1.76×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends90%58%26%-6%Gross margin, FY2021: 37.30%Gross margin, FY2022: 36.76%Gross margin, FY2023: 37.98%Gross margin, FY2024: 39.72%Gross margin, FY2025: 82.26%Operating margin, FY2021: 14.73%Operating margin, FY2022: 12.17%Operating margin, FY2023: 12.22%Operating margin, FY2024: 28.82%Operating margin, FY2025: 16.14%Net margin, FY2021: 4.69%Net margin, FY2022: 2.14%Net margin, FY2023: 2.97%Net margin, FY2024: 15.49%Net margin, FY2025: 6.60%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 37.30%. Gross margin FY2022 36.76%. Gross margin FY2023 37.98%. Gross margin FY2024 39.72%. Gross margin FY2025 82.26%. Operating margin FY2021 14.73%. Operating margin FY2022 12.17%. Operating margin FY2023 12.22%. Operating margin FY2024 28.82%. Operating margin FY2025 16.14%. Net margin FY2021 4.69%. Net margin FY2022 2.14%. Net margin FY2023 2.97%. Net margin FY2024 15.49%. Net margin FY2025 6.60%.

Income trends

Revenue

21.31B USD+3.12%

Operating income

3.44B USD-42.26%

Net income

1.41B USD-56.03%
Income trends across reported periods23.4B USD15.04B USD6.68B USD−1.68B USDRevenue, FY2021: 19.49B USDRevenue, FY2022: 19.17B USDRevenue, FY2023: 20.55B USDRevenue, FY2024: 20.67B USDRevenue, FY2025: 21.31B USDOperating income, FY2021: 2.87B USDOperating income, FY2022: 2.33B USDOperating income, FY2023: 2.51B USDOperating income, FY2024: 5.96B USDOperating income, FY2025: 3.44B USDNet income, FY2021: 914M USDNet income, FY2022: 411M USDNet income, FY2023: 611M USDNet income, FY2024: 3.2B USDNet income, FY2025: 1.41B USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 19.49B USD. Revenue FY2022 19.17B USD. Revenue FY2023 20.55B USD. Revenue FY2024 20.67B USD. Revenue FY2025 21.31B USD. Operating income FY2021 2.87B USD. Operating income FY2022 2.33B USD. Operating income FY2023 2.51B USD. Operating income FY2024 5.96B USD. Operating income FY2025 3.44B USD. Net income FY2021 914M USD. Net income FY2022 411M USD. Net income FY2023 611M USD. Net income FY2024 3.2B USD. Net income FY2025 1.41B USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue21.31B USD20.67B USD20.55B USD19.17B USD19.49B USD
Cost of goods sold3.78B USD12.46B USD12.74B USD12.13B USD12.22B USD
Gross profit17.53B USD8.21B USD7.81B USD7.05B USD7.27B USD
Selling, general, and administrative8.71B USD8.8B USD418M USD412M USD412M USD
Operating expenses14.09B USD2.25B USD5.3B USD4.72B USD4.4B USD
Interest expense821M USD826M USD901M USD890M USD923M USD
Depreciation and amortization863M USD818M USD870M USD841M USD855M USD
Operating income3.44B USD5.96B USD2.51B USD2.33B USD2.87B USD
Net income1.41B USD3.2B USD611M USD411M USD914M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
100%
11 beats, 0 misses, 0 met estimates
Average EPS surprise
+38.08%
11 comparable reports
Latest EPS result
6.12
Estimate 4.26 · Beat by 43.66%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates6.385.123.872.61Q1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 12, 2025: actual 3.44, estimate 2.95, surprise +16.61%, Beat. Q2 2025, reported Apr 29, 2025: actual 4.36, estimate 3.12, surprise +39.74%, Beat. Q3 2025, reported Jul 22, 2025: actual 4.02, estimate 2.87, surprise +40.07%, Beat. Q4 2025, reported Oct 28, 2025: actual 3.7, estimate 3.34, surprise +10.78%, Beat. Q1 2026, reported Feb 11, 2026: actual 4.7, estimate 4.07, surprise +15.48%, Beat. Q2 2026, reported Apr 30, 2026: actual 4.82, estimate 4.17, surprise +15.59%, Beat. Q3 2026, reported Jul 23, 2026: actual 6.12, estimate 4.26, surprise +43.66%, Beat. Q4 2026, reported Oct 27, 2026: actual —, estimate 4.64, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates5.85B5.52B5.18B4.85BQ1 '25MissQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26MissQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 12, 2025: actual 5.07B USD, estimate 5.17B USD, surprise -1.85%, Miss. Q2 2025, reported Apr 29, 2025: actual 5.22B USD, estimate 5.14B USD, surprise +1.65%, Beat. Q3 2025, reported Jul 22, 2025: actual 5.27B USD, estimate 5.16B USD, surprise +2.14%, Beat. Q4 2025, reported Oct 28, 2025: actual 5.29B USD, estimate 5.26B USD, surprise +0.64%, Beat. Q1 2026, reported Feb 11, 2026: actual 5.53B USD, estimate 5.47B USD, surprise +1.01%, Beat. Q2 2026, reported Apr 30, 2026: actual 5.37B USD, estimate 5.39B USD, surprise -0.47%, Miss. Q3 2026, reported Jul 23, 2026: actual 5.63B USD, estimate 5.43B USD, surprise +3.62%, Beat. Q4 2026, reported Oct 27, 2026: actual —, estimate 5.49B USD, surprise —, Comparison unavailable.

THC news

THC peers

ETFs holding THC

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research THC

research.disclaimer